HCA Healthcare (HCA) Fundamental Analysis: Revenue, Earnings & Valuation

5.75 / 10

Netural

HCA Healthcare's fundamental score is 5.8/10, signaling average quality. Bullish aspects include a high net profit ratio to net profit (87.1755), strong cash-to-market value (Cash-MV: 0.2941), and solid asset-to-market value (Asset-MV: -0.5284). However, concerns arise from revenue-to-market value (Revenue-MV: 0.8760) and the PB-ROE factor (0.8276), which place the stock in less favorable quartiles. Historical back-tests show mixed returns across metrics, with Cash-MV yielding 6.92% monthly returns and Net income-Revenue at 6.72%, while PB-ROE and Revenue-MV have negative or modest gains. The Quick ratio of 0.8643 is in the first group, indicating potential liquidity tightness. Overall, the fundamentals are a blend of strengths and weaknesses, warranting a balanced view.

Analysis Checks(5/10)

Revenue-MV

Value0.88

Score1/3

Weight4.39%

1M Return1.35%

Net profit attributable to parent company shareholders / Net profit (%)

Value87.18

Score3/3

Weight11.92%

1M Return3.44%

Net income-Revenue

Value0.29

Score3/3

Weight24.90%

1M Return6.72%

Quick ratio

Value0.86

Score2/3

Weight6.50%

1M Return1.96%

PB-ROE

Value0.83

Score0/3

Weight-0.59%

1M Return-0.18%

Basic earnings per share (YoY growth rate %)

Value29.02

Score1/3

Weight2.42%

1M Return0.73%

Net cash flow from operating activities (YoY growth rate %)

Value20.18

Score1/3

Weight3.13%

1M Return1.01%

Diluted earnings per share (YoY growth rate %)

Value28.77

Score1/3

Weight3.40%

1M Return1.01%

Asset-MV

Value-0.53

Score2/3

Weight17.71%

1M Return4.43%

Cash-MV

Value0.29

Score3/3

Weight26.22%

1M Return6.92%

Is HCA undervalued or overvalued?

HCA scores 5.75/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 10.29% net margin, 16.88 P/E ratio, -41.31 P/B ratio, and 29.02% earnings growth, these metrics solidify its Netural investment rating.